Search Results
Alpha Synuclein Research in POTS: a New Mechanism?
Parkinson’s Disease Pathophysiology: A Focus on Alpha-Synuclein
Is α-synuclein a useful therapeutic target in Parkinson's disease?
Targeting α-synuclein as a therapy for Parkinson’s disease: strategies in the pipeline
Alpha Synuclein Aggregates Targeting by Free-floating IFA | Protocol Preview
Multiple System Atrophy (MSA): Diagnosis, Treatment and Future Research
Rare Autonomic Disorders-Steven Vernino, MD, PhD & Kishan Tarpara, DO
Alpha-Synuclein Strains in Synucleinopathies
NET Dysfunction in POTS: 2017 Conference Research Study
The Basics of Parkinson Disease - Dean Sutherland, MD, PhD (Parkinson's Expo 2020)
Protein aggregation and Parkinson’s disease - Dr Sophie Morgan
Creating New Neurons: The Potential to Reverse Parkinson’s Disease
